Anika collabs to develop injectable stem cell therapy for osteoarthritis
Anika Therapeutics (NSDQ:ANIK) has inked an agreement with the Institute of Integrative Biology at the University of Liverpool to develop an injectable mesenchymal stem cell therapy to treat osteoarthritis.
As a result of the three-year research collaboration, the group hopes to have a lead candidate that it can take into clinical trials.
Get the full story at our sister site, Drug Delivery Business News.
The post Anika collabs to develop injectable stem cell therapy for osteoarthritis appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Orthopedics Pharmaceuticals Research & Development Stem Cells Wall Street Beat Anika Therapeutics Inc. University of Liverpool Source Type: news
More News: Biology | Clinical Trials | Orthopaedics | Osteoarthritis | Stem Cell Therapy | Stem Cells